Danielle Porter to Middle East Respiratory Syndrome Coronavirus
This is a "connection" page, showing publications Danielle Porter has written about Middle East Respiratory Syndrome Coronavirus.
Connection Strength
0.087
-
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus. J Biol Chem. 2020 04 10; 295(15):4773-4779.
Score: 0.044
-
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun. 2020 01 10; 11(1):222.
Score: 0.043